Simvastatin promotes osteogenic differentiation of mouse embryonic stem cells via canonical Wnt/β-catenin signaling
- 294 Downloads
Simvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, has been known to reduce cholesterol biosynthesis. However, recent studies demonstrate that simvastatin shows diverse cholesterol-independent functions including cellular differentiation. In this study, we investigated the stimulatory effect of simvastatin on the osteogenic differentiation of mouse embryonic stem cells (ESCs). The osteogenic effect of simvastatin was observed at relatively low doses (ranging from 1 nM to 200 nM). Incubation of ESCs in simvastatin-supplemented osteogenic medium significantly increased alkaline phosphatase (ALP) activity at day 7. The matrix mineralization was also augmented and demonstrated pivotal levels after 14 days incubation of simvastatin. Osteogenic differentiation of ESCs by simvastatin was determined by upregulation of the mRNA expression of runtrelated gene 2 (Runx2), osterix (OSX), and osteocalcin (OCN) as osteogenic transcription factors. Moreover, the increased protein expression of OCN, osteopontin (OPN), and collagen type I (Coll I) was assessed using Western blot analysis and immunocytochemistry. However, the blockage of canonical Wnt signaling by DKK-1 downregulated simvastatin-induced ALP activity and the mRNA expression of each osteogenic transcription factor. Furthermore, the β-catenin specific siRNA transfection decreased the protein levels of OCN, OPN, and Coll I. Collectively, these findings suggest that simvastatin enhances the differentiation of ESCs toward osteogenic lineage through activation of canonical Wnt/β-catenin signaling.
Keywordscanonical Wnt/β-catenin signaling embryonic stem cells osteogenic differentiation simvastatin
Unable to display preview. Download preview PDF.
- Grebenová, D., Kuzelová, K., Smetana, K., Pluskalová, M., Cajthamlová, H., Marinov, I., Fuchs, O., Soucek, J., Jarolím, P., and Hrkal, Z. (2003). Mitochondrial and endoplasmic reticulum stress-induced apoptotic pathways are activated by 5-aminolevulinic acid-based photodynamic therapy in HL60 leukemia cells. J. Photochem. Photobiol. B. 69, 71–85.PubMedCrossRefGoogle Scholar
- Kato, M., Patel, M.S., Levasseur, R., Lobov, I., Chang, B.H., Glass 2nd, D.A., Hartmann, C., Li, L., Hwang, T.H., Brayton, C.F., et al. (2002). Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J. Cell Biol. 157, 303–314.PubMedCrossRefGoogle Scholar
- Kim, S.Y., Kim, S., Yun-Choi, H.S., and Jho, E.H. (2011). Wnt5a potentiates U46619-induced platelet aggregation via the PI3K/Akt pathway. Mol. Cells [Epub ahead of print].Google Scholar
- Montagnani, A., Gonnelli, S., Cepollaro, C., Pacini, S., Campagna, M.S., Franci, M.B., Lucani, B., and Gennari, C. (2003). Effect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic postmenopausal women: a 1-year longitudinal study. Bone 32, 427–433.PubMedCrossRefGoogle Scholar
- Ruiz-Gaspa, S., Nogues, X., Enjuanes, A., Monllau, J.C., Blanch, J., Carreras, R., Mellibovsky, L., Grinberg, D., Balcells, S., Díez-Perez, A., et al. (2007). Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures. J. Cell. Biochem. 101, 1430–1438.PubMedCrossRefGoogle Scholar
- Zhang, L., Zhang, L., Tian, F., Han, D., Niu, J., and Liu, X. (2009). Effect of simvastatin on mRNA expressions of some components of Wnt signaling pathway in differentiation process of osteoblasts derived from BMSCs of rats. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 23, 1371–1375.PubMedGoogle Scholar